GENEVA, SWITZERLAND / / December 23, 2025 / MindMaze Therapeutics Holding SA (SIX: MMTX ) (MindMaze Therapeutics or the Company), a commercial-stage company delivering evidence-based, precision digit ...
Abstract: Embedded machine learning applications face challenges related to massive data movement and high computational intensity, exacerbated by the limited performance of mobile devices.